LifeStance Health forecasts FY adjusted EBITDA of $242–250 million
The outlook compares with an IBES estimate of $228.6 million.
Story updates
11:07:59 AM UTC
SquawkNews
LifeStance Health Group Raises 2026 Adj EBITDA View to $242M-$250M >LFST